title: Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
authors.forename: G
authors.initials: G
authors.lastname: Bertelli
authors.forename: M A
authors.initials: MA
authors.lastname: Cafferata
authors.forename: A
authors.initials: A
authors.lastname: Ardizzoni
authors.forename: A
authors.initials: A
authors.lastname: Gozza
authors.forename: R
authors.initials: R
authors.lastname: Rosso
authors.forename: D
authors.initials: D
authors.lastname: Dini
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000077143:Docetaxel; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000188:drug therapy*; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D017239:Paclitaxel / Q000009:adverse effects / Q000031:analogs & derivatives; D012883:Skin Ulcer / Q000139:chemically induced*; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D006821:Hyaluronoglucosaminidase; D017239:Paclitaxel